Trials / Active Not Recruiting
Active Not RecruitingNCT06630169
Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
APANECA: A Prospective, Parallel-arm, Multi-Surgeon Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (2024-E002-C)
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Aurion Biotech · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of cryopreserved AURN001 in patients with corneal edema secondary to endothelial dysfunction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Cryopreserved AURN001 | Corneal Endothelial Cells and Y27632 |
Timeline
- Start date
- 2024-09-16
- Primary completion
- 2025-10-01
- Completion
- 2025-10-01
- First posted
- 2024-10-08
- Last updated
- 2025-01-28
Locations
1 site across 1 country: El Salvador
Source: ClinicalTrials.gov record NCT06630169. Inclusion in this directory is not an endorsement.